In active development · CTAS-informed · Canadian-hosted

AI medical triage,
made in Canada.

MapleTriage is an AI-assisted triage and documentation tool being built for Canadian healthcare teams — capture a patient's symptoms quickly, structure them clearly, and guide the patient toward the right level of care. Designed CTAS-informed and privacy-first, with a clinician owning every acuity decision. In active development and not yet generally available.

Talk to us about a pilot Where things stand
MapleTriage patient intake preview: symptom form with CTAS acuity scale + MapleTriage · Intake concept PATIENT INTAKE AI Hi, what brings you in today? Patient Sharp chest pain, started 30 min ago. Radiates to left arm. AI Pain scale 0-10? Any shortness of breath, nausea, sweating? Patient 8/10. Yes — short of breath. ⚠ ESCALATING TO ON-CALL NURSE Possible STEMI · 911 ambulance dispatched RN Sarah connecting in 12 sec CTAS ACUITY I · Resuscitation Immediate · this patient 1 II · Emergent ≤ 15 min · cardiac chest pain III · Urgent ≤ 30 min · mod. asthma IV · Less Urgent ≤ 60 min · sprain, UTI V · Non-urgent ≤ 120 min · prescription refill Design preview Illustration only · not live data ⚕
CTAS
Canadian scale, not US ESI
100% CA
Data residency by design
20+ yrs
Team telephone-triage experience
NRC IRAP
Application in progress
What's inside

Designed for Canadian clinical reality

Six design principles behind MapleTriage. These are build goals for a product in active development — not shipped, validated or certified capabilities.

Pre-arrival symptom intake

Voice, SMS or web. A structured, CTAS-informed interview that captures the patient's own words before they reach the desk.

CTAS-informed acuity

Built against the 2018 CTAS Adult and Pediatric guidelines so outputs speak the Canadian scale — chief complaint, modifiers and rationale, not the US ESI.

Clinician owns every decision

MapleTriage does not diagnose, treat or replace a licensed provider. High-acuity or low-confidence cases are designed to escalate to your on-call nurse, never to resolve on their own.

EMR write-back (roadmap)

FHIR-based write-back to Canadian EMRs such as Accuro, OSCAR and Telus PSS is a design goal. No connector is shipped or certified today.

Bilingual (EN/FR)

English and French (Canadian) are the launch target — New Brunswick is the only officially bilingual province. Further languages come after.

Regulatory posture, stated plainly

MapleTriage is not a licensed medical device and holds no regulatory approval. Where a triage tool sits under Health Canada SaMD rules is being assessed as part of the design.

In the wild

See it in action

Clinical front-desk triage that respects PHIPA, PIPEDA, and provincial rules.

MapleTriage clinical dashboard on a tablet alongside a stethoscope in a Canadian medical practice with maple trees through the window
Triage pipeline

How a MapleTriage intake is designed to flow

The four-step pipeline we are building for family practice, urgent care and nurse-triage lines. Every step below is a design goal, not a shipped feature.

1

Patient initiates contact

Voice call, SMS, or in-room iPad before reaching the desk. AI greets in the patient's preferred language.

2

Structured symptom interview

CEDIS chief complaint identified, vital signs captured (if iPad), CTAS modifiers scored, red flags surfaced.

3

Acuity suggestion for clinician review

A CTAS-informed acuity suggestion with its rationale, for a clinician to confirm or override. High acuity or low confidence escalates instead of resolving.

4

Clean note for the chart

A structured, reviewable note handed to the clinician. Direct EMR write-back to Accuro / OSCAR / Telus PSS is on the roadmap, not shipped.

Why MapleTriage

Built by a team with 20+ years in telephone triage

We've spent two decades inside telephone triage operations — handling the calls, designing the workflows, and seeing where every existing tool falls short. MapleTriage is what we are building to fix that.

How we stack up

MapleTriage vs. the alternatives

What MapleTriage is being built to do differently. The MapleTriage column describes design goals for a product in active development, not shipped capabilities.

Feature MapleTriage TriageLogic Generic LLM ClearTriage Schmitt-Thompson (content licence) Epic MyChart Triage Spruce Health Outsourced Nurse Call Centre (US)
CTAS-informed (not US ESI) Design target ESI Schmitt-Thompson (US) Schmitt-Thompson (US) Primarily ESI — Schmitt-Thompson (US)
EMR write-back (Accuro/OSCAR/PSS) Roadmap PDF / print; HL7 add-on Not applicable (content only) Epic-native only US EHR integrations Faxback / phone callback
Canadian PHI residency By design Variable US-hosted Content only (no PHI) Tenant-controlled US-hosted US-hosted
Health Canada SaMD pathway Under assessment Out of scope None Out of scope Out of scope Out of scope Out of scope Out of scope
Mandatory human-in-loop By design Live RN Designed for nurse use Designed for nurse use Clinical user Clinical user Live RN
EN/FR support EN/FR at launch EN/FR Variable EN (FR via licensed translations) EN (translations available) Configurable Primarily EN EN (FR varies)
Conversational AI (LLM) intake In development Generic / unguarded Protocol-driven (no LLM) Protocol-driven (no LLM) AI features rolling out Messaging AI assist
Pricing model Not set yet Not published Per-token Per-user / per-month (USD) Content licence (USD) Bundled with Epic Per-seat / per-month (USD) Per-call or per-nurse-hour (USD)
Starts at Not yet available Not published Per-token Quote / site Quote / site Epic contract Quote / site Quote / call volume
Where things stand

MapleTriage is not available yet

It is in active development. There is no signup, no trial and no published price. We are talking with Canadian healthcare partners now.

Follow the build

mapletriage.com carries the dated build log, a reference library on Canadian health systems and health-data law, and a plain statement of what MapleTriage is and is not.

Open mapletriage.com →

Talk to us about a pilot

Walk us through your triage workflow. We will show where the build actually is, what we are designing toward, and what an early pilot could look like. 30 minutes.

Book a 30-minute call →
NRC IRAP application in progress. MapleTriage is pursuing innovation funding through the National Research Council Industrial Research Assistance Program, with technical-readiness documentation and a structured evaluation underway. No funding has been awarded.
Important. MapleTriage is a triage and documentation support tool. It does not diagnose, treat, or replace a licensed healthcare provider. Patients should always consult a qualified clinician for medical decisions. MapleTriage holds no regulatory approval and has not been clinically validated.
Works best with

Companion Maple products

Some features in Mapletriage need a companion Maple product to reach customers. Add them anytime from your dashboard.

MapleReceptionist (Concierge) Required

Enables: SMS + voice intake

Learn more →
MapleVoice Required

Enables: SMS + voice intake

Learn more →
Questions & answers

Frequently asked

Is MapleTriage approved by Health Canada as a Software as a Medical Device (SaMD)?
No. MapleTriage is not a licensed medical device and is not marketed as one. It is an early-stage product in active development, designed as a triage documentation and intake support tool. It does not diagnose, treat, or replace a licensed healthcare provider — a registered nurse, paramedic or physician owns every acuity decision. If the product scope later requires a medical device licence, we will complete that process before making any such claim.
How does MapleTriage differ from a nurse-staffed telephone triage service?
A nurse-staffed telephone triage service is people answering calls. MapleTriage is software: a Canadian-hosted, CTAS-informed intake and documentation tool intended to support the clinicians you already have, not to replace them. It is in active development and not yet generally available, so we are not making head-to-head performance or cost comparisons against any specific vendor.
Will MapleTriage integrate with our EMR?
EMR integration is on the roadmap, not shipped. No EMR connectors are live today and we have no production EMR installations. The design intent is standards-based FHIR integration so that a completed intake can be written back as a structured note, but treat that as a design goal we have not yet delivered. If EMR write-back is a hard requirement for you, MapleTriage is not ready for you yet.
How does MapleTriage relate to CTAS?
MapleTriage is CTAS-informed: the intake flow and the vocabulary it captures are structured around the Canadian Triage and Acuity Scale and CEDIS chief-complaint coding, so the documentation it produces lines up with how Canadian clinicians already work. That is a design orientation, not a certification — MapleTriage is not endorsed, accredited or validated by CAEP, CIHI or any CTAS governing body, and the clinician assigns the acuity level.
What languages will MapleTriage support?
English and French (Canadian) are the target languages for launch. Because the product is still in development, treat this as a commitment we are building toward rather than a shipped capability. Additional languages are not scheduled.
Has MapleTriage been clinically validated?
Not yet. We have no published validation study, no accuracy or sensitivity figures, and no peer-reviewed results — and we will not quote any until a real study exists. Anyone citing performance numbers for MapleTriage today is citing something we did not measure. Clinical evaluation is part of the technical-readiness work underway.
How is clinician oversight designed to work?
The core design principle is that MapleTriage never owns an acuity decision. It is intended to capture and structure the intake, surface what was reported, and hand a clinician a complete, reviewable record — with the clinician setting the acuity and any escalation. Specific escalation routing and notification behaviour is still being designed and is not available to evaluate today.
Who is behind MapleTriage and how is it funded?
MapleTriage is developed by the MapleWorkSuite team in New Brunswick, Canada, and is self-funded. We are pursuing innovation funding through the National Research Council Industrial Research Assistance Program (NRC IRAP) — an application in progress, not funding awarded. MapleTriage has no clinical advisory board, no hospital partners and no health-authority endorsements at this time. When any of that changes we will name it here.
Is there a free plan for MapleTriage?
Yes. MapleTriage offers a free account so you can start with no credit card and no commitment. Create your free account, explore the core features, and upgrade to a paid plan only when you need more volume or advanced capabilities.

Building triage that belongs in Canada.

MapleTriage is early, and we are talking with Canadian healthcare partners now. 30-minute call, no obligation.

Talk to us about a pilot Where things stand